JCOM Paid Subscribers LOG IN user name: password:   Forgot password?		J Clin Outcomes Manage  2012 Nov;19(11):501-517 Therapeutic options in steroid-refractory acute severe ulcerative colitis Blonski W, Mudireddy PR, Buchner AM, Lichtenstein GR Abstract Objective: To review therapeutic options in patients with steroid-refractory severe ulcerative colitis (UC). Methods: Review of the literature. Results: UC is characterized by periods of active and inactive disease, a pattern observed in 80% to 90% of patients with this disease. About 15% to 25% of patients with UC will present with a severe attack at least once in their lifetime. Usual treatment for acute severe UC is intravenous corticosteroids, but about 30% to 40% of patients fail to respond to steroids. Patients presenting with severe corticosteroid-refractory disease can be treated medically with cyclosporine, infliximab, or tacrolimus or undergo emergent proctocolectomy. Conclusion: Currently there is no ideal treatment of choice in patients with severe steroid-refractory UC. Further studies are needed to determine the best treatment for these patients. Clinical Review Article Search the Turner White index to find abstracts of articles published in JCOM.
New issues are posted one month following publication of the printed journal. View past issue archives:    2011    2010    2009    2008    2007    2006    2005    2004    2003     2002     2001     2000     1999 Hospital Physician     JCOM     Seminars in Medical Practice Hospital Physician Board Review Manuals About TWC    Subscribe    Contact TWC    Home    Search   Site Map Copyright © 2013, Turner White Communications Updated 7/14/09 • nvf